Innovating.works Conecta tu I+D

Showing 1 to 20 of 36 results

MPS_NOVA: MPS NOVA Hub Advanced Microphysiological Systems and Pluripotent Stem Cell Technologies to Unveil C... Mitigating the current rise in chronic diseases and effectively addressing the enduring challenges posed by infectious diseases are pressing...
2024-05-28 - 2027-09-30 | Financiado

APPEAL: Antivirus Pandemic Preparedness EuropeAn pLatform UNIVERSITATSKLINIKUM JENA tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Developing new antiviral treatment against viruses and particularly high-priority emerging and re-emerging viruses as listed by the WHO, rem...
2024-01-01 - 2028-12-31 | Financiado

METAFUN: Metabolic control of immune cell function during fungal infection UNIVERSITATSKLINIKUM JENA participó en un HORIZON EUROPE: HORIZON-WIDERA-2022-TALENTS-04 The high mortality rates and healthcare costs associated with severe fungal infections highlight the urgent need to unveil their pathogeneti...
2023-05-10 - 2025-09-30 | Financiado

CHARM: Chemometric histopathology via coherent Raman imaging for precision medicine UNIVERSITATSKLINIKUM JENA participó en un HORIZON EUROPE: HORIZON-EIC-2021-TRANSITION-CHALLENGES-01 The CHARM project aims to radically transform the cancer diagnosing process and bring the emerging field of digital histopathology to the ne...
2022-03-22 - 2025-10-31 | Financiado

TROPHY: ulTRafast hOlograPHic FTIR microscopY UNIVERSITATSKLINIKUM JENA participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDEROPEN-01 Many human pathologies such as cancer are due to complex biochemical alterations that start at a sub-cellular level and lead to progressive...
2022-03-04 - 2026-02-28 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research UNIVERSITATSKLINIKUM JENA participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

Inno4Vac: Innovations to accelerate vaccine development and manufacture UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling...
2021-07-19 - 2027-02-28 | Financiado

NECTAR: NEutron Capture enhanced Treatment of neurotoxic Amyloid aggRegates UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-FETOPEN-2018-2020 NECTAR proposes an alternative and revolutionary strategy to address AD (Alzheimer’s Disease) treatment, suggesting and investigating a ther...
2021-01-20 - 2024-09-30 | Financiado

CRIMSON: Coherent Raman Imaging for the Molecular Study of the OrigiN of diseases UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-ICT-2018-20 CRIMSON aims to provide a next-generation bio-photonics imaging device based on vibrational spectroscopy, with the potential to revolutionis...
2020-11-30 - 2024-05-31 | Financiado

SmartAge: Gut brain axis Targets for improvement of cognition in the elderly UNIVERSITATSKLINIKUM JENA tramitó un H2020: H2020-MSCA-ITN-2019 In Europe, the population is aging. The age-associated decline in cognitive functions represents a serious social and medical problem. Recen...
2020-06-22 - 2025-02-28 | Financiado

ImmunoSep: Personalized immunotherapy in sepsis a precision medicine based approach UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-SC1-BHC-2018-2020 Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, and is characterized by a high mortality...
2019-12-05 - 2024-06-30 | Financiado

imSAVAR: Immune Safety Avatar nonclinical mimicking of the immune system effects of immunomodulatory therapi... UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy saf...
2019-11-18 - 2025-11-30 | Financiado

ONCORNET2.0: ONCOgenic Receptor Network of Excellence and Training 2.0 UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-MSCA-ITN-2019 Cancer is a major health burden responsible for 20% of European deaths. There is a critical need to understand its fundamental biological me...
2019-08-27 - 2024-01-31 | Financiado

TIPAT: Training towards Personalized Antibiotic Treatment UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-MSCA-ITN-2019 Antimicrobial resistance (AMR) is an increasing threat to effectively treat serious bacterial infections. To this end, tailoring antibiotic...
2019-08-12 - 2024-08-31 | Financiado

FAT4BRAIN: Networking for excellence in functional pharmacology to study the role of fatty acid metabolism in n... UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-WIDESPREAD-2018-2020 The Latvian Institute of Organic Synthesis (LIOS) is in great need to enhance its scientific performance and this could be accomplished thro...
2019-06-18 - 2023-04-30 | Financiado

EUROoC: Interdisciplinary training network for advancing Organ on a chip technology in Europe UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-MSCA-ITN-2018 EUROoC will create a trans-European network of industrially oriented specialists fully trained in development and application of the emergin...
2018-08-21 - 2023-05-31 | Financiado

TOBeATPAIN: Targeting neuroinflammation to combat pathological pain in neurodegenerative diseases and chronic pa... UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-MSCA-ITN-2017 Damage to the central (CNS) and peripheral (PNS) nervous systems causes altered perception of pain (pathological pain) which is a common fea...
2018-07-05 - 2022-07-31 | Financiado

IMI-PainCare: Improving the care of patients suffering from acute or chronic pain UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-JTI-IMI2-2016-10-two-stage There is a very high need for improving the management of pain. Acute and persistent pain of different origins represent a common medical, s...
2018-05-04 - 2023-03-31 | Financiado

FRESCOatCNAP: FrontierResearchCompentences@CNAP UNIVERSITATSKLINIKUM JENA participó en un H2020: H2020-MSCA-COFUND-2016 Chronic pain is a key societal challenge affecting one out of five adults and is in general poorly treated. This programme, FrontierResearch...
2017-03-30 - 2022-03-31 | Financiado